|
OMIM |
Link |
Information gain |
01 |
|
SLEB3
|
[NCBI]
|
0.00223193
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.00176385
|
|
|
IBD2
|
[NCBI]
|
0.00165048
|
|
|
UFS
|
[NCBI]
|
0.00152247
|
|
|
IS1
|
[NCBI]
|
0.00125737
|
|
|
CRC
|
[NCBI]
|
0.00123728
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.00121344
|
|
|
NNCI
|
[NCBI]
|
0.00111508
|
|
|
myopia 14
|
[NCBI]
|
0.00111508
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.00111508
|
|
|
melanoma, uveal, susceptibility to, 2
|
[NCBI]
|
0.00111508
|
|
|
RCM2
|
[NCBI]
|
0.00111508
|
|
|
porokeratosis, disseminated superficial actinic, 2
|
[NCBI]
|
0.00111508
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.00111508
|
|
|
GLC1C
|
[NCBI]
|
0.00105074
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.00105074
|
|
|
RA
|
[NCBI]
|
0.00100042
|
|
|
CF
|
[NCBI]
|
0.000991788
|
|
|
SLE
|
[NCBI]
|
0.000959432
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.000909491
|
|
|
CNC2
|
[NCBI]
|
0.000909491
|
|
|
PSORS2
|
[NCBI]
|
0.000855435
|
|
|
AUTS4
|
[NCBI]
|
0.000801219
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000801219
|
|
|
MCKD1
|
[NCBI]
|
0.000792199
|
|
|
MTS
|
[NCBI]
|
0.000782201
|
|
|
cataract, central saccular, with sutural opacities
|
[NCBI]
|
0.0007604
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.0007604
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.0007604
|
|
|
IDDM13
|
[NCBI]
|
0.0007604
|
|
|
stature quantitative trait locus 5
|
[NCBI]
|
0.0007604
|
|
|
amyotrophic lateral sclerosis 6
|
[NCBI]
|
0.0007604
|
|
|
IDDM15
|
[NCBI]
|
0.0007604
|
|
|
IBD9
|
[NCBI]
|
0.0007604
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000713863
|
|
|
DURS1
|
[NCBI]
|
0.000684358
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.00067759
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
0.00067759
|
|
|
lynch syndrome i
|
[NCBI]
|
0.000625701
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.000605934
|
|
|
ALSFTD1
|
[NCBI]
|
0.000605934
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.000605934
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.000605934
|
|
|
nonpapillary renal carcinoma 1
|
[NCBI]
|
0.000605934
|
|
|
parkinson disease 12
|
[NCBI]
|
0.000605934
|
|
|
CORD8
|
[NCBI]
|
0.000605934
|
|
|
DSMA3
|
[NCBI]
|
0.000605934
|
|
|
HPCX
|
[NCBI]
|
0.000578981
|
|
|
restless legs syndrome, susceptibility to, 4
|
[NCBI]
|
0.000557317
|
|
|
SQTL1
|
[NCBI]
|
0.000557317
|
|
|
melanoma, uveal, susceptibility to, 1
|
[NCBI]
|
0.000557317
|
|
|
DFNA30
|
[NCBI]
|
0.000557317
|
|
|
cataract, crystalline coralliform
|
[NCBI]
|
0.000557317
|
|
|
RP32
|
[NCBI]
|
0.000557317
|
|
|
RP22
|
[NCBI]
|
0.000557317
|
|
|
MRX72
|
[NCBI]
|
0.000557317
|
|
|
hypotrichosis simplex
|
[NCBI]
|
0.000557317
|
|
|
DFNB66
|
[NCBI]
|
0.000557317
|
|
|
wegener granulomatosis
|
[NCBI]
|
0.000557317
|
|
|
abidi x-linked mental retardation syndrome
|
[NCBI]
|
0.000557317
|
|
|
panic disorder 2
|
[NCBI]
|
0.000557317
|
|
|
RP28
|
[NCBI]
|
0.000557317
|
|
|
MRX52
|
[NCBI]
|
0.000557317
|
|
|
GLC1K
|
[NCBI]
|
0.000557317
|
|
|
MRT4
|
[NCBI]
|
0.000557317
|
|
|
RP33
|
[NCBI]
|
0.000557317
|
|
|
myoclonic epilepsy, infantile
|
[NCBI]
|
0.000557317
|
|
|
BMND6
|
[NCBI]
|
0.000557317
|
|
|
aortic aneurysm, familial abdominal 1
|
[NCBI]
|
0.000557317
|
|
|
AMCX5
|
[NCBI]
|
0.000557317
|
|
|
GLC1B
|
[NCBI]
|
0.000557317
|
|
|
GLC1F
|
[NCBI]
|
0.000557317
|
|
|
IBD8
|
[NCBI]
|
0.000557317
|
|
|
azoospermia, nonobstructive
|
[NCBI]
|
0.000557317
|
|
|
SPG24
|
[NCBI]
|
0.000557317
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.000557317
|
|
|
DFNA47
|
[NCBI]
|
0.000557317
|
|
|
WM2
|
[NCBI]
|
0.000557317
|
|
|
CILD2
|
[NCBI]
|
0.000557317
|
|
|
SPAX2
|
[NCBI]
|
0.000557317
|
|
|
DFNA43
|
[NCBI]
|
0.000557317
|
|
|
SQTL2
|
[NCBI]
|
0.000557317
|
|
|
MRX73
|
[NCBI]
|
0.000557317
|
|
|
LAH3
|
[NCBI]
|
0.000557317
|
|
|
spinal muscular atrophy, distal, x-linked recessive
|
[NCBI]
|
0.000557317
|
|
|
preauricular tag, isolated, autosomal dominant, 1
|
[NCBI]
|
0.000557317
|
|
|
DFNM1
|
[NCBI]
|
0.000557317
|
|
|
MRX53
|
[NCBI]
|
0.000557317
|
|
|
migraine with aura, susceptibility to, 9
|
[NCBI]
|
0.000557317
|
|
|
autoimmune thyroid disease, susceptibility to, 4
|
[NCBI]
|
0.000557317
|
|
|
ovarian cancer, epithelial, susceptibility to
|
[NCBI]
|
0.000557317
|
|
|
major depressive disorder 1
|
[NCBI]
|
0.000557317
|
|
|
moyamoya disease 3
|
[NCBI]
|
0.000557317
|
|
|
OTSC2
|
[NCBI]
|
0.000557317
|
|
|
high density lipoprotein deficiency 3
|
[NCBI]
|
0.000557317
|
|
|
CATCN1
|
[NCBI]
|
0.000557317
|
|
|
acropectoral syndrome
|
[NCBI]
|
0.000557317
|
|
|
bone size quantitative trait locus 3
|
[NCBI]
|
0.000557317
|
|
|
RP23
|
[NCBI]
|
0.000557317
|
|
|
MCOPCB1
|
[NCBI]
|
0.000557317
|
|
|
STHAG5
|
[NCBI]
|
0.000557317
|
|
|
myopia 13
|
[NCBI]
|
0.000557317
|
|
|
anisomastia
|
[NCBI]
|
0.000557317
|
|
|
EJM4
|
[NCBI]
|
0.000557317
|
|
|
ATFB2
|
[NCBI]
|
0.000557317
|
|
|
SPOAN
|
[NCBI]
|
0.000557317
|
|
|
psoriasis susceptibility 7
|
[NCBI]
|
0.000557317
|
|
|
ETM3
|
[NCBI]
|
0.000557317
|
|
|
prostate cancer, hereditary, 7
|
[NCBI]
|
0.000557317
|
|
|
OTSC5
|
[NCBI]
|
0.000557317
|
|
|
PNKD2
|
[NCBI]
|
0.000557317
|
|
|
DFNB26
|
[NCBI]
|
0.000557317
|
|
|
dyskeratosis, hereditary benign intraepithelial
|
[NCBI]
|
0.000557317
|
|
|
SPG28
|
[NCBI]
|
0.000557317
|
|
|
SCKL3
|
[NCBI]
|
0.000557317
|
|
|
narcolepsy 2
|
[NCBI]
|
0.000557317
|
|
|
EIG2
|
[NCBI]
|
0.000557317
|
|
|
FEB6
|
[NCBI]
|
0.000557317
|
|
|
myopia 12
|
[NCBI]
|
0.000557317
|
|
|
GLC1J
|
[NCBI]
|
0.000557317
|
|
|
MYMY2
|
[NCBI]
|
0.000557317
|
|
|
peripheral arterial occlusive disease 1
|
[NCBI]
|
0.000557317
|
|
|
aortic aneurysm, familial abdominal 2
|
[NCBI]
|
0.000557317
|
|
|
armfield x-linked mental retardation syndrome
|
[NCBI]
|
0.000557317
|
|
|
HSCR8
|
[NCBI]
|
0.000557317
|
|
|
stature quantitative trait locus 4
|
[NCBI]
|
0.000557317
|
|
|
FGS4
|
[NCBI]
|
0.000557317
|
|
|
aneurysm, intracranial berry, 2
|
[NCBI]
|
0.000557317
|
|
|
DFNB68
|
[NCBI]
|
0.000557317
|
|
|
SPG29
|
[NCBI]
|
0.000557317
|
|
|
spondyloarthropathy, susceptibility to, 2
|
[NCBI]
|
0.000557317
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
0.000503234
|
|
|
SPG12
|
[NCBI]
|
0.000503234
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000503234
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.000503234
|
|
|
AD14
|
[NCBI]
|
0.000503234
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000503234
|
|
|
DYT7
|
[NCBI]
|
0.000503234
|
|
|
CORD7
|
[NCBI]
|
0.000503234
|
|
|
AD13
|
[NCBI]
|
0.000503234
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000427022
|
|
|
CCA1
|
[NCBI]
|
0.000427022
|
|
|
CHED1
|
[NCBI]
|
0.000427022
|
|
|
HMN7A
|
[NCBI]
|
0.000427022
|
|
|
SRS
|
[NCBI]
|
0.000394336
|
|
|
AS
|
[NCBI]
|
0.000391789
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.000367116
|
|
|
MEAX
|
[NCBI]
|
0.000367116
|
|
|
BMND3
|
[NCBI]
|
0.000367116
|
|
|
MYMY1
|
[NCBI]
|
0.000367116
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000367116
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.000367116
|
|
|
IBD1
|
[NCBI]
|
0.000361655
|
|
|
MDD
|
[NCBI]
|
0.000343406
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000318737
|
|
|
autism
|
[NCBI]
|
0.000309524
|
|
|
AITD3
|
[NCBI]
|
0.000305005
|
|
|
MRT12
|
[NCBI]
|
0.00030277
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 4
|
[NCBI]
|
0.00030277
|
|
|
myopia 5
|
[NCBI]
|
0.00030277
|
|
|
DFNA7
|
[NCBI]
|
0.00030277
|
|
|
DFNB13
|
[NCBI]
|
0.00030277
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.00030277
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.00030277
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.00030277
|
|
|
IBD4
|
[NCBI]
|
0.00030277
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.00030277
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.00030277
|
|
|
myasthenia, familial infantile, 1
|
[NCBI]
|
0.00030277
|
|
|
AIS2
|
[NCBI]
|
0.00030277
|
|
|
migraine with or without aura, susceptibility to, 10
|
[NCBI]
|
0.00030277
|
|
|
GLC1I
|
[NCBI]
|
0.00030277
|
|
|
migraine with or without aura, susceptibility to, 11
|
[NCBI]
|
0.00030277
|
|
|
AIS3
|
[NCBI]
|
0.00030277
|
|
|
FSHMD1B
|
[NCBI]
|
0.00030277
|
|
|
LGMD1F
|
[NCBI]
|
0.00030277
|
|
|
intelligence quantitative trait locus 1
|
[NCBI]
|
0.00030277
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.00030277
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.00030277
|
|
|
cone-rod dystrophy and amelogenesis imperfecta
|
[NCBI]
|
0.00030277
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.00030277
|
|
|
acute insulin response
|
[NCBI]
|
0.00030277
|
|
|
ATOD5
|
[NCBI]
|
0.00030277
|
|
|
BMND5
|
[NCBI]
|
0.00030277
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.00030277
|
|
|
MCOPCB2
|
[NCBI]
|
0.00030277
|
|
|
prostate cancer, hereditary, 9
|
[NCBI]
|
0.00030277
|
|
|
CELIAC5
|
[NCBI]
|
0.00030277
|
|
|
MAFD4
|
[NCBI]
|
0.00030277
|
|
|
brachydactyly, type a1, b
|
[NCBI]
|
0.00030277
|
|
|
NEM6
|
[NCBI]
|
0.00030277
|
|
|
alzheimer disease 7
|
[NCBI]
|
0.00030277
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.00030277
|
|
|
MNG2
|
[NCBI]
|
0.00030277
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.0002782
|
|
|
SCZD6
|
[NCBI]
|
0.000277562
|
|
|
PWS
|
[NCBI]
|
0.00026212
|
|
|
MLH1
|
[NCBI]
|
0.000255433
|
|
|
PSORS1
|
[NCBI]
|
0.000249712
|
|
|
dermatitis, atopic
|
[NCBI]
|
0.000242939
|
|
|
AMCN
|
[NCBI]
|
0.000242939
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
0.000239197
|
|
|
AD
|
[NCBI]
|
0.00023825
|
|
|
MAFD1
|
[NCBI]
|
0.000236127
|
|
|
MSH6
|
[NCBI]
|
0.000230609
|
|
|
BHD
|
[NCBI]
|
0.000230249
|
|
|
PDB
|
[NCBI]
|
0.000222454
|
|
|
CHED2
|
[NCBI]
|
0.000218242
|
|
|
RMD1
|
[NCBI]
|
0.000213338
|
|
|
IDDM17
|
[NCBI]
|
0.000213338
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.000213338
|
|
|
CFM1
|
[NCBI]
|
0.000213338
|
|
|
HSCR9
|
[NCBI]
|
0.000213338
|
|
|
DIH2
|
[NCBI]
|
0.000213338
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.000213338
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.000213338
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000213338
|
|
|
LI5
|
[NCBI]
|
0.000213338
|
|
|
cavitary optic disc anomalies
|
[NCBI]
|
0.000213338
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.000213338
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000213338
|
|
|
migraine without aura, susceptibility to, 4
|
[NCBI]
|
0.000213338
|
|
|
CSE
|
[NCBI]
|
0.000213338
|
|
|
myopia 6
|
[NCBI]
|
0.000213338
|
|
|
laterality defects, autosomal dominant
|
[NCBI]
|
0.000213338
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
0.000213338
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
0.000213338
|
|
|
erythrokeratodermia variabilis 3
|
[NCBI]
|
0.000213338
|
|
|
IBD6
|
[NCBI]
|
0.000213338
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.000213338
|
|
|
DYT15
|
[NCBI]
|
0.000213338
|
|
|
PSORS3
|
[NCBI]
|
0.000213338
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.000213338
|
|
|
wilms tumor 4
|
[NCBI]
|
0.000213338
|
|
|
IDDM11
|
[NCBI]
|
0.000213338
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000213338
|
|
|
macrocephaly with multiple epiphyseal dysplasia and distinctive facies
|
[NCBI]
|
0.000213338
|
|
|
SPG19
|
[NCBI]
|
0.000213338
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.000213338
|
|
|
OFC2
|
[NCBI]
|
0.000213338
|
|
|
PARK10
|
[NCBI]
|
0.000213338
|
|
|
ALSFTD2
|
[NCBI]
|
0.000213338
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000213338
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.000213338
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.000213338
|
|
|
GLC1M
|
[NCBI]
|
0.000213338
|
|
|
patent ductus arteriosus
|
[NCBI]
|
0.000213338
|
|
|
SCAR6
|
[NCBI]
|
0.000213338
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.000213338
|
|
|
testicular microlithiasis
|
[NCBI]
|
0.000213338
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
0.000213132
|
|
|
OTSC1
|
[NCBI]
|
0.000213132
|
|
|
IBD5
|
[NCBI]
|
0.000213132
|
|
|
HPC1
|
[NCBI]
|
0.000207739
|
|
|
CJD
|
[NCBI]
|
0.000202716
|
|
|
EGF
|
[NCBI]
|
0.000201561
|
|
|
SCA6
|
[NCBI]
|
0.000194234
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
0.000184486
|
|
|
CTPP3
|
[NCBI]
|
0.000179224
|
|
|
DFNA6
|
[NCBI]
|
0.000177656
|
|
|
ALUNC
|
[NCBI]
|
0.000177656
|
|
|
IDDM4
|
[NCBI]
|
0.000164492
|
|
|
spondyloocular syndrome, autosomal recessive
|
[NCBI]
|
0.000163962
|
|
|
CCA3
|
[NCBI]
|
0.000163962
|
|
|
SCZD9
|
[NCBI]
|
0.000163552
|
|
|
osteoarthritis
|
[NCBI]
|
0.000162087
|
|
|
SCZD
|
[NCBI]
|
0.000161213
|
|
|
HMPS1
|
[NCBI]
|
0.000159003
|
|
|
keratolytic winter erythema
|
[NCBI]
|
0.000159003
|
|
|
DYX5
|
[NCBI]
|
0.000159003
|
|
|
ALS5
|
[NCBI]
|
0.000159003
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000159003
|
|
|
DYX3
|
[NCBI]
|
0.000159003
|
|
|
MPD2
|
[NCBI]
|
0.000159003
|
|
|
dupuytren contracture
|
[NCBI]
|
0.000159003
|
|
|
ICCA
|
[NCBI]
|
0.000159003
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000159003
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000159003
|
|
|
MYP3
|
[NCBI]
|
0.000159003
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
0.000159003
|
|
|
DYX6
|
[NCBI]
|
0.000159003
|
|
|
CTAA2
|
[NCBI]
|
0.000159003
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000159003
|
|
|
thyroid carcinoma, hurthle cell
|
[NCBI]
|
0.000159003
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000159003
|
|
|
sclerotylosis
|
[NCBI]
|
0.000159003
|
|
|
HHC3
|
[NCBI]
|
0.000159003
|
|
|
autism, susceptibility to, 3
|
[NCBI]
|
0.000159003
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.000159003
|
|
|
SCZD5
|
[NCBI]
|
0.000159003
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000159003
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
0.000159003
|
|
|
NIDDM
|
[NCBI]
|
0.00015681
|
|
|
JPS
|
[NCBI]
|
0.000156381
|
|
|
HNSCC
|
[NCBI]
|
0.000151543
|
|
|
WT5
|
[NCBI]
|
0.000151543
|
|
|
VEGF
|
[NCBI]
|
0.000150683
|
|
|
MYP2
|
[NCBI]
|
0.000144461
|
|
|
MSH2
|
[NCBI]
|
0.000141796
|
|
|
OPLL
|
[NCBI]
|
0.00014162
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000139006
|
|
|
SCA10
|
[NCBI]
|
0.000132871
|
|
|
VWS
|
[NCBI]
|
0.000130833
|
|
|
NGFB
|
[NCBI]
|
0.000127915
|
|
|
PAND1
|
[NCBI]
|
0.000126716
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000126716
|
|
|
microduplication 22q11.2
|
[NCBI]
|
0.000126043
|
|
|
BOS3
|
[NCBI]
|
0.000126043
|
|
|
CNC1
|
[NCBI]
|
0.000125069
|
|
|
CMDR
|
[NCBI]
|
0.000121338
|
|
|
CTPP1
|
[NCBI]
|
0.000121338
|
|
|
CELIAC2
|
[NCBI]
|
0.000121338
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000121338
|
|
|
CTAA1
|
[NCBI]
|
0.000121338
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000121338
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.000121338
|
|
|
USH2B
|
[NCBI]
|
0.000121338
|
|
|
IBD3
|
[NCBI]
|
0.000121338
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000121338
|
|
|
SCZD2
|
[NCBI]
|
0.000119531
|
|
|
prostate cancer
|
[NCBI]
|
0.000119467
|
|
|
PJS
|
[NCBI]
|
0.000119449
|
|
|
MAFD6
|
[NCBI]
|
0.000115121
|
|
|
melanoma-astrocytoma syndrome
|
[NCBI]
|
0.000109089
|
|
|
VAMAS1
|
[NCBI]
|
0.000109089
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
0.000109089
|
|
|
AIS1
|
[NCBI]
|
0.000109089
|
|
|
LI3
|
[NCBI]
|
0.000109089
|
|
|
DPR
|
[NCBI]
|
0.000109089
|
|
|
ED2
|
[NCBI]
|
0.000108642
|
|
|
BBS
|
[NCBI]
|
0.000108201
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000107848
|
|
|
hypertension, essential
|
[NCBI]
|
0.000106358
|
|
|
MG
|
[NCBI]
|
0.000106026
|
|
|
MLH3
|
[NCBI]
|
0.000105458
|
|
|
PTH
|
[NCBI]
|
0.000103417
|
|
|
PALS
|
[NCBI]
|
9.96315e-05
|
|
|
MCPH1
|
[NCBI]
|
9.96315e-05
|
|
|
SCA7
|
[NCBI]
|
9.77743e-05
|
|
|
CCZS
|
[NCBI]
|
9.75565e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
9.75565e-05
|
|
|
MRX54
|
[NCBI]
|
9.75565e-05
|
|
|
LI2
|
[NCBI]
|
9.75565e-05
|
|
|
novelty seeking personality trait
|
[NCBI]
|
9.75565e-05
|
|
|
NPHP4
|
[NCBI]
|
9.75565e-05
|
|
|
gastric cancer
|
[NCBI]
|
9.58692e-05
|
|
|
PFM
|
[NCBI]
|
9.5657e-05
|
|
|
PRL
|
[NCBI]
|
9.50371e-05
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
9.34927e-05
|
|
|
SCAX1
|
[NCBI]
|
9.34927e-05
|
|
|
vestibulopathy, familial
|
[NCBI]
|
9.34927e-05
|
|
|
SCZD10
|
[NCBI]
|
9.34927e-05
|
|
|
MKS2
|
[NCBI]
|
9.34927e-05
|
|
|
RNANC
|
[NCBI]
|
9.34927e-05
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
9.34927e-05
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
9.34927e-05
|
|
|
EKD2
|
[NCBI]
|
9.34927e-05
|
|
|
HPC10
|
[NCBI]
|
9.34927e-05
|
|
|
NIDDM2
|
[NCBI]
|
9.34927e-05
|
|
|
DYX2
|
[NCBI]
|
9.19722e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
9.19722e-05
|
|
|
SPG4
|
[NCBI]
|
9.13636e-05
|
|
|
MRT1
|
[NCBI]
|
8.87975e-05
|
|
|
RP17
|
[NCBI]
|
8.87975e-05
|
|
|
RP13
|
[NCBI]
|
8.87975e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
8.85404e-05
|
|
|
FHM2
|
[NCBI]
|
8.85404e-05
|
|
|
DHS
|
[NCBI]
|
8.43178e-05
|
|
|
CDAN2
|
[NCBI]
|
8.43178e-05
|
|
|
CACNA1A
|
[NCBI]
|
8.28342e-05
|
|
|
MSS
|
[NCBI]
|
8.2321e-05
|
|
|
mycobacterium tuberculosis, susceptibility to, x-linked
|
[NCBI]
|
8.1973e-05
|
|
|
angioma, tufted
|
[NCBI]
|
8.1973e-05
|
|
|
PFMCCD
|
[NCBI]
|
8.1973e-05
|
|
|
CATCN3
|
[NCBI]
|
8.1973e-05
|
|
|
USH2D
|
[NCBI]
|
8.1973e-05
|
|
|
hepatic adenomas, familial
|
[NCBI]
|
8.1973e-05
|
|
|
epilepsy, x-linked, with variable learning disabilities and behavior disorders
|
[NCBI]
|
8.1973e-05
|
|
|
cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome
|
[NCBI]
|
8.1973e-05
|
|
|
3-@methylglutaconic aciduria, type v
|
[NCBI]
|
8.1973e-05
|
|
|
cutis verticis gyrata, retinitis pigmentosa, and sensorineural deafness
|
[NCBI]
|
8.1973e-05
|
|
|
ROCA
|
[NCBI]
|
8.1973e-05
|
|
|
peters anomaly with cataract
|
[NCBI]
|
8.1973e-05
|
|
|
systemic lupus erythematosus, susceptibility to, 9
|
[NCBI]
|
8.1973e-05
|
|
|
craniosynostosis syndrome, autosomal recessive
|
[NCBI]
|
8.1973e-05
|
|
|
ATFB3
|
[NCBI]
|
8.1973e-05
|
|
|
CCA2
|
[NCBI]
|
8.1746e-05
|
|
|
naegeli syndrome
|
[NCBI]
|
8.1746e-05
|
|
|
IDDM5
|
[NCBI]
|
8.1746e-05
|
|
|
pierson syndrome
|
[NCBI]
|
8.1746e-05
|
|
|
CZP3
|
[NCBI]
|
8.1746e-05
|
|
|
TGFBR2
|
[NCBI]
|
7.83948e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
7.58566e-05
|
|
|
vitiligo
|
[NCBI]
|
7.58566e-05
|
|
|
AMDM
|
[NCBI]
|
7.58566e-05
|
|
|
PEE1
|
[NCBI]
|
7.40909e-05
|
|
|
SCZD3
|
[NCBI]
|
7.30918e-05
|
|
|
DM2
|
[NCBI]
|
7.29179e-05
|
|
|
APC
|
[NCBI]
|
7.26898e-05
|
|
|
AVP
|
[NCBI]
|
7.25119e-05
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
7.21355e-05
|
|
|
IH
|
[NCBI]
|
7.21355e-05
|
|
|
APS2
|
[NCBI]
|
7.21355e-05
|
|
|
DBQD
|
[NCBI]
|
7.21355e-05
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
7.21355e-05
|
|
|
CFEOM3
|
[NCBI]
|
7.21355e-05
|
|
|
SPG5A
|
[NCBI]
|
7.21355e-05
|
|
|
renal cell carcinoma, papillary, 3
|
[NCBI]
|
7.21355e-05
|
|
|
PSORS4
|
[NCBI]
|
7.21355e-05
|
|
|
MICA
|
[NCBI]
|
7.14617e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
7.08111e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
7.08111e-05
|
|
|
NPHP3
|
[NCBI]
|
7.08111e-05
|
|
|
SPG10
|
[NCBI]
|
7.08111e-05
|
|
|
CMT2D
|
[NCBI]
|
7.08111e-05
|
|
|
IL10
|
[NCBI]
|
7.06636e-05
|
|
|
IL6R
|
[NCBI]
|
7.03583e-05
|
|
|
CFNS
|
[NCBI]
|
6.96025e-05
|
|
|
MHA
|
[NCBI]
|
6.96025e-05
|
|
|
SHFM1
|
[NCBI]
|
6.84015e-05
|
|
|
DYX1
|
[NCBI]
|
6.74317e-05
|
|
|
SNCA
|
[NCBI]
|
6.65892e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
6.64068e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
6.64068e-05
|
|
|
PKD3
|
[NCBI]
|
6.64068e-05
|
|
|
MCPH5
|
[NCBI]
|
6.64068e-05
|
|
|
BRIC1
|
[NCBI]
|
6.64068e-05
|
|
|
SPG17
|
[NCBI]
|
6.64068e-05
|
|
|
TCF7L2
|
[NCBI]
|
6.53008e-05
|
|
|
GFAP
|
[NCBI]
|
6.50078e-05
|
|
|
WFS1
|
[NCBI]
|
6.4337e-05
|
|
|
AMC
|
[NCBI]
|
6.42312e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
6.33839e-05
|
|
|
EPO
|
[NCBI]
|
6.31473e-05
|
|
|
JBTS1
|
[NCBI]
|
6.30538e-05
|
|
|
PCOS1
|
[NCBI]
|
6.28497e-05
|
|
|
ATS
|
[NCBI]
|
6.25066e-05
|
|
|
RP11
|
[NCBI]
|
6.25066e-05
|
|
|
SPG6
|
[NCBI]
|
6.25066e-05
|
|
|
HNPCC2
|
[NCBI]
|
6.25066e-05
|
|
|
GINGF
|
[NCBI]
|
6.25066e-05
|
|
|
OCD1
|
[NCBI]
|
6.25066e-05
|
|
|
LRP5
|
[NCBI]
|
6.23157e-05
|
|
|
MYH9
|
[NCBI]
|
6.23157e-05
|
|
|
NOTCH4
|
[NCBI]
|
6.21674e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
6.14924e-05
|
|
|
MEN1
|
[NCBI]
|
6.11448e-05
|
|
|
CCK
|
[NCBI]
|
6.10588e-05
|
|
|
MBD4
|
[NCBI]
|
5.99338e-05
|
|
|
MS
|
[NCBI]
|
5.9767e-05
|
|
|
graves disease
|
[NCBI]
|
5.96806e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
5.90132e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
5.90132e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
5.90132e-05
|
|
|
SNDI
|
[NCBI]
|
5.90132e-05
|
|
|
CYLD
|
[NCBI]
|
5.90132e-05
|
|
|
CMT2B
|
[NCBI]
|
5.90132e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
5.74431e-05
|
|
|
behcet syndrome
|
[NCBI]
|
5.74431e-05
|
|
|
BDNF
|
[NCBI]
|
5.71792e-05
|
|
|
LEP
|
[NCBI]
|
5.71634e-05
|
|
|
ALD
|
[NCBI]
|
5.68122e-05
|
|
|
CRH
|
[NCBI]
|
5.63083e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
5.62749e-05
|
|
|
FLCN
|
[NCBI]
|
5.61846e-05
|
|
|
ZNF9
|
[NCBI]
|
5.61846e-05
|
|
|
NPY
|
[NCBI]
|
5.58736e-05
|
|
|
ARH
|
[NCBI]
|
5.58552e-05
|
|
|
DSMA1
|
[NCBI]
|
5.58552e-05
|
|
|
THC2
|
[NCBI]
|
5.58552e-05
|
|
|
CMT2A1
|
[NCBI]
|
5.58552e-05
|
|
|
FTNS
|
[NCBI]
|
5.58552e-05
|
|
|
NCIE1
|
[NCBI]
|
5.58552e-05
|
|
|
neuroticism
|
[NCBI]
|
5.53905e-05
|
|
|
MCOPS1
|
[NCBI]
|
5.53905e-05
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
5.53905e-05
|
|
|
gastroesophageal reflux
|
[NCBI]
|
5.53905e-05
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
5.53905e-05
|
|
|
FKTN
|
[NCBI]
|
5.4578e-05
|
|
|
WFS2
|
[NCBI]
|
5.45367e-05
|
|
|
mental retardation, x-linked, with short stature, small testes, muscle wasting, and tremor
|
[NCBI]
|
5.45367e-05
|
|
|
PPCD3
|
[NCBI]
|
5.45367e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
5.45367e-05
|
|
|
microphthalmia, isolated, with cataract 4
|
[NCBI]
|
5.45367e-05
|
|
|
LGMD2G
|
[NCBI]
|
5.45367e-05
|
|
|
SLSN4
|
[NCBI]
|
5.45367e-05
|
|
|
myelofibrosis, familial
|
[NCBI]
|
5.45367e-05
|
|
|
IS3
|
[NCBI]
|
5.45367e-05
|
|
|
HMPS2
|
[NCBI]
|
5.45367e-05
|
|
|
retinopathy, pigmentary, and mental retardation
|
[NCBI]
|
5.45367e-05
|
|
|
JBTS4
|
[NCBI]
|
5.45367e-05
|
|
|
CLSD
|
[NCBI]
|
5.45367e-05
|
|
|
pilomatrixoma
|
[NCBI]
|
5.45367e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
5.45367e-05
|
|
|
williams-beuren region duplication syndrome
|
[NCBI]
|
5.45367e-05
|
|
|
dystonia, juvenile-onset
|
[NCBI]
|
5.45367e-05
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
5.45367e-05
|
|
|
brevican
|
[NCBI]
|
5.45367e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
5.45367e-05
|
|
|
heterotopia, periventricular, autosomal recessive
|
[NCBI]
|
5.45367e-05
|
|
|
MRX45
|
[NCBI]
|
5.45367e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
5.45367e-05
|
|
|
PPCD2
|
[NCBI]
|
5.45367e-05
|
|
|
LCCS2
|
[NCBI]
|
5.45367e-05
|
|
|
DFNA44
|
[NCBI]
|
5.45367e-05
|
|
|
urticaria, familial localized heat
|
[NCBI]
|
5.45367e-05
|
|
|
MRXS10
|
[NCBI]
|
5.45367e-05
|
|
|
bothnia retinal dystrophy
|
[NCBI]
|
5.45367e-05
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
5.45367e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
5.45367e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2l
|
[NCBI]
|
5.45367e-05
|
|
|
KLK3
|
[NCBI]
|
5.3292e-05
|
|
|
MSX2
|
[NCBI]
|
5.31093e-05
|
|
|
ATXN2
|
[NCBI]
|
5.31093e-05
|
|
|
AGS1
|
[NCBI]
|
5.29783e-05
|
|
|
sitosterolemia
|
[NCBI]
|
5.29783e-05
|
|
|
PNDM
|
[NCBI]
|
5.29783e-05
|
|
|
SUCLA2
|
[NCBI]
|
5.27182e-05
|
|
|
FANCA
|
[NCBI]
|
5.23538e-05
|
|
|
MAFD2
|
[NCBI]
|
5.21898e-05
|
|
|
SHOX
|
[NCBI]
|
5.17459e-05
|
|
|
FCAS
|
[NCBI]
|
5.16432e-05
|
|
|
NOD2
|
[NCBI]
|
5.11545e-05
|
|
|
BCNS
|
[NCBI]
|
5.11388e-05
|
|
|
PCNA
|
[NCBI]
|
5.06615e-05
|
|
|
COCH
|
[NCBI]
|
5.05039e-05
|
|
|
FOXP2
|
[NCBI]
|
5.05039e-05
|
|
|
SVAS
|
[NCBI]
|
5.03837e-05
|
|
|
esophageal cancer
|
[NCBI]
|
5.03407e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
5.03407e-05
|
|
|
GAN1
|
[NCBI]
|
5.03407e-05
|
|
|
SOST
|
[NCBI]
|
5.03407e-05
|
|
|
WFS1
|
[NCBI]
|
5.02113e-05
|
|
|
BMPR1A
|
[NCBI]
|
4.93369e-05
|
|
|
NF1
|
[NCBI]
|
4.89488e-05
|
|
|
CRYBA1
|
[NCBI]
|
4.82451e-05
|
|
|
CYP11A1
|
[NCBI]
|
4.82451e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
4.79092e-05
|
|
|
HSAN2
|
[NCBI]
|
4.79092e-05
|
|
|
NBIA1
|
[NCBI]
|
4.79092e-05
|
|
|
ALOXE3
|
[NCBI]
|
4.7611e-05
|
|
|
GLC1A
|
[NCBI]
|
4.74965e-05
|
|
|
HSCR1
|
[NCBI]
|
4.72929e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
4.56569e-05
|
|
|
SPCH1
|
[NCBI]
|
4.56569e-05
|
|
|
CACNA1S
|
[NCBI]
|
4.53385e-05
|
|
|
MPO
|
[NCBI]
|
4.49603e-05
|
|
|
MCPH6
|
[NCBI]
|
4.43911e-05
|
|
|
FECD1
|
[NCBI]
|
4.43911e-05
|
|
|
male infertility with large-headed, multiflagellar, polyploid spermatozoa
|
[NCBI]
|
4.43911e-05
|
|
|
carcinoid tumors, intestinal
|
[NCBI]
|
4.43911e-05
|
|
|
MRT3
|
[NCBI]
|
4.43911e-05
|
|
|
SCA11
|
[NCBI]
|
4.43911e-05
|
|
|
pierre robin syndrome
|
[NCBI]
|
4.43911e-05
|
|
|
spondyloepiphyseal dysplasia, kimberley type
|
[NCBI]
|
4.43911e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
4.43911e-05
|
|
|
LCA4
|
[NCBI]
|
4.43911e-05
|
|
|
dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema
|
[NCBI]
|
4.43911e-05
|
|
|
DFNB31
|
[NCBI]
|
4.43911e-05
|
|
|
otofaciocervical syndrome
|
[NCBI]
|
4.43911e-05
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
4.43911e-05
|
|
|
SPS
|
[NCBI]
|
4.43911e-05
|
|
|
urticaria, aquagenic
|
[NCBI]
|
4.43911e-05
|
|
|
ATOD4
|
[NCBI]
|
4.43911e-05
|
|
|
MRX63
|
[NCBI]
|
4.43911e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
4.43911e-05
|
|
|
MRX58
|
[NCBI]
|
4.43911e-05
|
|
|
aortic aneurysm, familial thoracic 4
|
[NCBI]
|
4.43911e-05
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
4.43911e-05
|
|
|
HMERF
|
[NCBI]
|
4.43911e-05
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
4.43911e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
4.43911e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
4.43911e-05
|
|
|
SLEB2
|
[NCBI]
|
4.43911e-05
|
|
|
DDU
|
[NCBI]
|
4.43911e-05
|
|
|
meniere disease
|
[NCBI]
|
4.43911e-05
|
|
|
ABCA12
|
[NCBI]
|
4.41135e-05
|
|
|
IGER
|
[NCBI]
|
4.3758e-05
|
|
|
HGF
|
[NCBI]
|
4.35789e-05
|
|
|
DCC
|
[NCBI]
|
4.26098e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
4.21799e-05
|
|
|
kabuki syndrome
|
[NCBI]
|
4.21799e-05
|
|
|
CRYAA
|
[NCBI]
|
4.21122e-05
|
|
|
SCZD7
|
[NCBI]
|
4.20942e-05
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
4.20942e-05
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
4.20942e-05
|
|
|
IGES
|
[NCBI]
|
4.20942e-05
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
4.20942e-05
|
|
|
MYOC
|
[NCBI]
|
4.20255e-05
|
|
|
GEFS+
|
[NCBI]
|
4.16065e-05
|
|
|
JBS
|
[NCBI]
|
4.16065e-05
|
|
|
IBM2
|
[NCBI]
|
4.16065e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
4.16065e-05
|
|
|
KCNQ1
|
[NCBI]
|
4.14707e-05
|
|
|
SLC11A1
|
[NCBI]
|
4.14707e-05
|
|
|
SLC2A10
|
[NCBI]
|
4.14397e-05
|
|
|
ALOX12B
|
[NCBI]
|
4.14397e-05
|
|
|
FBN1
|
[NCBI]
|
4.08095e-05
|
|
|
PMS2
|
[NCBI]
|
4.07072e-05
|
|
|
ATXN8OS
|
[NCBI]
|
4.00473e-05
|
|
|
PLOSL
|
[NCBI]
|
3.97753e-05
|
|
|
HEPOD
|
[NCBI]
|
3.97753e-05
|
|
|
ORW2
|
[NCBI]
|
3.97753e-05
|
|
|
AAA
|
[NCBI]
|
3.97753e-05
|
|
|
polycythemia vera
|
[NCBI]
|
3.97753e-05
|
|
|
OFC1
|
[NCBI]
|
3.97169e-05
|
|
|
CTNNA2
|
[NCBI]
|
3.92729e-05
|
|
|
WHRN
|
[NCBI]
|
3.92729e-05
|
|
|
HRPT2
|
[NCBI]
|
3.92729e-05
|
|
|
CHMP4B
|
[NCBI]
|
3.92729e-05
|
|
|
ARX
|
[NCBI]
|
3.88021e-05
|
|
|
NHS
|
[NCBI]
|
3.80556e-05
|
|
|
EDMD2
|
[NCBI]
|
3.80556e-05
|
|
|
APL
|
[NCBI]
|
3.80556e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
3.79209e-05
|
|
|
HAE III
|
[NCBI]
|
3.79209e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
3.79209e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
3.79209e-05
|
|
|
PRTS
|
[NCBI]
|
3.79209e-05
|
|
|
LAH
|
[NCBI]
|
3.79209e-05
|
|
|
CORD6
|
[NCBI]
|
3.79209e-05
|
|
|
HHF4
|
[NCBI]
|
3.79209e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
3.79209e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
3.79209e-05
|
|
|
CFEOM2
|
[NCBI]
|
3.79209e-05
|
|
|
SPG8
|
[NCBI]
|
3.79209e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
3.79209e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
3.79209e-05
|
|
|
ependymoma, familial
|
[NCBI]
|
3.79209e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
3.79209e-05
|
|
|
HHF3
|
[NCBI]
|
3.79209e-05
|
|
|
CHBL
|
[NCBI]
|
3.79209e-05
|
|
|
USH1G
|
[NCBI]
|
3.79209e-05
|
|
|
rett syndrome, atypical, cdkl5-related
|
[NCBI]
|
3.79209e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
3.79209e-05
|
|
|
weill-marchesani syndrome, autosomal dominant
|
[NCBI]
|
3.79209e-05
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
3.79209e-05
|
|
|
LGMD2K
|
[NCBI]
|
3.79209e-05
|
|
|
MRT2
|
[NCBI]
|
3.79209e-05
|
|
|
PURE&apos
|
[NCBI]
|
3.79209e-05
|
|
|
SMS
|
[NCBI]
|
3.7878e-05
|
|
|
AVPR1A
|
[NCBI]
|
3.74512e-05
|
|
|
LAMB2
|
[NCBI]
|
3.74512e-05
|
|
|
TM4SF2
|
[NCBI]
|
3.74512e-05
|
|
|
IDDM
|
[NCBI]
|
3.70552e-05
|
|
|
PPH1
|
[NCBI]
|
3.64364e-05
|
|
|
GPR98
|
[NCBI]
|
3.58801e-05
|
|
|
MKKS
|
[NCBI]
|
3.58801e-05
|
|
|
FRZB
|
[NCBI]
|
3.58801e-05
|
|
|
MLC
|
[NCBI]
|
3.49084e-05
|
|
|
MORF4
|
[NCBI]
|
3.44995e-05
|
|
|
CDH13
|
[NCBI]
|
3.44995e-05
|
|
|
ANKH
|
[NCBI]
|
3.44995e-05
|
|
|
FCMD
|
[NCBI]
|
3.44506e-05
|
|
|
CAT
|
[NCBI]
|
3.38273e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
3.37494e-05
|
|
|
SCDO1
|
[NCBI]
|
3.34634e-05
|
|
|
KERA
|
[NCBI]
|
3.32685e-05
|
|
|
AAAS
|
[NCBI]
|
3.32685e-05
|
|
|
CACP
|
[NCBI]
|
3.31963e-05
|
|
|
JAE
|
[NCBI]
|
3.31963e-05
|
|
|
IDDM10
|
[NCBI]
|
3.31963e-05
|
|
|
IDDM12
|
[NCBI]
|
3.31963e-05
|
|
|
CSCD
|
[NCBI]
|
3.31963e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
3.31963e-05
|
|
|
RTADR
|
[NCBI]
|
3.31963e-05
|
|
|
KRS
|
[NCBI]
|
3.31963e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
3.31963e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
3.31963e-05
|
|
|
pulmonary alveolar microlithiasis
|
[NCBI]
|
3.31963e-05
|
|
|
MRX59
|
[NCBI]
|
3.31963e-05
|
|
|
STL3
|
[NCBI]
|
3.31963e-05
|
|
|
POF2A
|
[NCBI]
|
3.31963e-05
|
|
|
monosomy 9p syndrome
|
[NCBI]
|
3.31963e-05
|
|
|
AH
|
[NCBI]
|
3.31963e-05
|
|
|
HCHOLA3
|
[NCBI]
|
3.31963e-05
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
3.31963e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
3.31963e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
3.31963e-05
|
|
|
SPS
|
[NCBI]
|
3.29019e-05
|
|
|
PTEN
|
[NCBI]
|
3.25184e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
3.24033e-05
|
|
|
MSH3
|
[NCBI]
|
3.21583e-05
|
|
|
MLC1
|
[NCBI]
|
3.21583e-05
|
|
|
BRIP1
|
[NCBI]
|
3.21583e-05
|
|
|
PITX3
|
[NCBI]
|
3.21583e-05
|
|
|
ASPM
|
[NCBI]
|
3.21583e-05
|
|
|
SCN8A
|
[NCBI]
|
3.21583e-05
|
|
|
KCNQ4
|
[NCBI]
|
3.21583e-05
|
|
|
BFSP2
|
[NCBI]
|
3.21583e-05
|
|
|
OR1F1
|
[NCBI]
|
3.20231e-05
|
|
|
CYP4F22
|
[NCBI]
|
3.20231e-05
|
|
|
CACNA2D3
|
[NCBI]
|
3.20231e-05
|
|
|
pantothenate kinase 3
|
[NCBI]
|
3.20231e-05
|
|
|
radial ray deficiency, x-linked
|
[NCBI]
|
3.20231e-05
|
|
|
C9ORF103
|
[NCBI]
|
3.20231e-05
|
|
|
TTC12
|
[NCBI]
|
3.20231e-05
|
|
|
CRYL1
|
[NCBI]
|
3.20231e-05
|
|
|
PABPC5
|
[NCBI]
|
3.20231e-05
|
|
|
RGSL1
|
[NCBI]
|
3.20231e-05
|
|
|
SUV420H1
|
[NCBI]
|
3.20231e-05
|
|
|
EBF3
|
[NCBI]
|
3.20231e-05
|
|
|
RASEF
|
[NCBI]
|
3.20231e-05
|
|
|
KCNA10
|
[NCBI]
|
3.20231e-05
|
|
|
mental retardation, x-linked, with short stature
|
[NCBI]
|
3.20231e-05
|
|
|
ZNF193
|
[NCBI]
|
3.20231e-05
|
|
|
C9ORF64
|
[NCBI]
|
3.20231e-05
|
|
|
narcolepsy candidate region gene 1a
|
[NCBI]
|
3.20231e-05
|
|
|
RGSL2
|
[NCBI]
|
3.20231e-05
|
|
|
pantothenate kinase 1
|
[NCBI]
|
3.20231e-05
|
|
|
C11ORF24
|
[NCBI]
|
3.20231e-05
|
|
|
TUSC1
|
[NCBI]
|
3.20231e-05
|
|
|
MPZL3
|
[NCBI]
|
3.20231e-05
|
|
|
IL1RL2
|
[NCBI]
|
3.20231e-05
|
|
|
ZNF192
|
[NCBI]
|
3.20231e-05
|
|
|
GNA14
|
[NCBI]
|
3.20231e-05
|
|
|
LY6G6D
|
[NCBI]
|
3.20231e-05
|
|
|
mental retardation, x-linked, south african type
|
[NCBI]
|
3.20231e-05
|
|
|
ST11
|
[NCBI]
|
3.20231e-05
|
|
|
BRAF
|
[NCBI]
|
3.16603e-05
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
3.14753e-05
|
|
|
PARK3
|
[NCBI]
|
3.14753e-05
|
|
|
|